Felix Lichtenegger

Vice President Clinical Development @CatalYm GmbH

Munich, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2024 — Present

Vice President Clinical Development @CatalYm GmbH

View department →

Martinsried, DE

Global Clinical Lead / Indication Lead for Visugromab

EDUCATION

1989 — 1998

Geschwister-Scholl-Gymnasium Waldkirch

Abitur

1999 — 2007

The University of Freiburg

Staatsexamen, Medicine

SKILLS

ImmunologyOncologyResearchCell CultureClinical TrialsClinical ResearchTumor ImmunologyHematologyLife SciencesCell BiologyMolecular BiologyPcrCancer ImmunotherapyScienceBiochemistryFlow Cytometry

ABOUT FELIX LICHTENEGGER

Senior Clinical Development Leader and board-certified hemato-oncologist with 18 years of combined clinical, scientific, and industry experience in hemato-oncology and immunology. Currently Vice President Clinical Development and Global Clinical Lead for a first-in-class immuno-therapy across lung and bladder cancer. Brings deep scientific expertise, broad clinical training, and strategic development acumen, with extensive experience in early- and mid-phase oncology trials (Phases I–IIb), spanning immunomodulatory agents, various T‑cell-targeting approaches, and cell therapies. Recognized for cross-functional leadership, regulatory engagement, and strong collaborations with Key Opinion Leaders and investigators, while mentoring and developing clin-ical and medical colleagues. Committed to advancing transformative therapies for patients with high unmet medical need.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Felix Lichtenegger — Vice President Clinical Development at CatalYm GmbH in Munich, DE | Unifers